Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01480024 · ClinicalTrials.gov registry record
Effect of Body Composition and Metabolism on Oocyte Gene Expression
A clinical trial, sponsored by Arkansas Children's Hospital Research Institute.
- Completed
- Registry status
- 46
- Enrollment target
NCT01480024: Completed study, sponsored by Arkansas Children's Hospital Research Institute.
NCT01480024 is a clinical trial that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01480024 has completed, sponsored by Arkansas Children's Hospital Research Institute.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The investigators will test the hypothesis that obese women have a unique oocyte gene expression profile that differs significantly from that of normal weight women.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2011-04 |
| Est. Completion | 2019-05-02 |
What the finished NCT01480024 record still lists
NCT01480024 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01480024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01480024 about?
NCT01480024 is a clinical study titled "Effect of Body Composition and Metabolism on Oocyte Gene Expression". The investigators will test the hypothesis that obese women have a unique oocyte gene expression profile that differs significantly from that of normal weight women.
What is the current status of trial NCT01480024?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2011-04. Estimated completion is 2019-05-02.
Who is sponsoring clinical trial NCT01480024?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia